Literature DB >> 15356655

Incidence and relevance of secondary chromosome abnormalities in childhood TEL/AML1+ acute lymphoblastic leukemia: an interphase FISH analysis.

A Attarbaschi1, G Mann, M König, M N Dworzak, M M Trebo, N Mühlegger, H Gadner, O A Haas.   

Abstract

The aim of the present study was to determine the frequency and clinical relevance of the most common secondary karyotype abnormalities in TEL/AML1+ B-cell precursor acute lymphoblastic leukemia (ALL) as assessed with fluorescence in situ hybridization (FISH) analyses. Screening of 372 patients who were enrolled in two consecutive Austrian childhood ALL multicenter trials identified 94 (25%) TEL/AML1+ cases. TEL deletions, trisomy 21 and an additional der(21)t(12;21) were detected in 52 (55%), 13 (14%) and 14 (15%) TEL/AML1+ patients, respectively. The 12p aberrations (P=0.001) and near tetraploidy (P=0.045) were more common in TEL/AML1+ patients, whereas the incidence of diploidy, pseudodiploidy, hypodiploidy, low hyperdiploidy, near triploidy, del(6q), chromosome 9 and 11q23 abnormalities was similar among TEL/AML1+ and TEL/AML1- patients. None of the TEL/AML1+ patients had a high hyperdiploid karyotype. Univariate analysis indicated that among TEL/AML1+ patients those with a deletion of the nontranslocated TEL allele had a worse prognosis than those without this abnormality (P=0.034). We concluded that the type and incidence of the most common secondary aberrations in TEL/AML1+ ALL can be conveniently identified with little additional effort during interphase screening with appropriate TEL and AML1 FISH probes. We also provided preliminary evidence that the deletion of the nontranslocated TEL allele may adversely influence the clinical course of TEL/AML1+ ALL.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15356655     DOI: 10.1038/sj.leu.2403471

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  11 in total

1.  Six cases of rare gene amplifications and multiple copy of fusion gene in childhood acute lymphoblastic leukemia.

Authors:  Irén Haltrich; Monika Csóka; Gábor Kovács; Dóra Török; Donát Alpár; Gábor Ottoffy; György Fekete
Journal:  Pathol Oncol Res       Date:  2012-04-24       Impact factor: 3.201

2.  Anti-apoptotic protein BCL2 down-regulates DNA end joining in cancer cells.

Authors:  Tadi Satish Kumar; Vijayalakshmi Kari; Bibha Choudhary; Mridula Nambiar; T S Akila; Sathees C Raghavan
Journal:  J Biol Chem       Date:  2010-08-10       Impact factor: 5.157

3.  ETV6 mutation in a cohort of 970 patients with hematologic malignancies.

Authors:  Qinrong Wang; Shasha Dong; Hong Yao; Lijun Wen; Huiying Qiu; Llili Qin; Liang Ma; Suning Chen
Journal:  Haematologica       Date:  2014-07-04       Impact factor: 9.941

4.  ETV6/RUNX1 abrogates mitotic checkpoint function and targets its key player MAD2L1.

Authors:  G Krapf; U Kaindl; A Kilbey; G Fuka; A Inthal; R Joas; G Mann; J C Neil; O A Haas; E R Panzer-Grümayer
Journal:  Oncogene       Date:  2010-03-01       Impact factor: 9.867

Review 5.  Prognostification of ALL by Cytogenetics.

Authors:  Ansar Hakeem; Aejaz Aziz Shiekh; Gull Mohd Bhat; A R Lone
Journal:  Indian J Hematol Blood Transfus       Date:  2014-12-11       Impact factor: 0.900

6.  Evaluation of ETV6/RUNX1 Fusion and Additional Abnormalities Involving ETV6 and/or RUNX1 Genes Using FISH Technique in Patients with Childhood Acute Lymphoblastic Leukemia.

Authors:  Cigdem Aydin; Zafer Cetin; Ayse Esra Manguoglu; Funda Tayfun; Ozden Altiok Clark; Alphan Kupesiz; Bahar Akkaya; Sibel Berker Karauzum
Journal:  Indian J Hematol Blood Transfus       Date:  2015-06-02       Impact factor: 0.900

Review 7.  Cytogenetics and molecular genetics of acute lymphoblastic leukemia.

Authors:  Krzysztof Mrózek; David P Harper; Peter D Aplan
Journal:  Hematol Oncol Clin North Am       Date:  2009-10       Impact factor: 3.722

8.  Cytogenetic Characteristics of Childhood Acute Lymphoblastic Leukemia: A Study of 1541 Chinese Patients Newly Diagnosed between 2001 and 2014.

Authors:  Meng-Meng Yin; Rui-Chi Wu; Jing Gao; Shao-Yan Hu; Xiao-Ming Liu; Xiao-Fan Zhu; Shu-Hong Shen; Jing-Yan Tang; Jing Chen; Qun Hu
Journal:  Curr Med Sci       Date:  2021-12-06

9.  Extra Copies of der(21)t(12;21) plus Deletion of ETV6 Gene due to dic(12;18) in B-Cell Precursor ALL with Poor Outcome.

Authors:  Marina Araújo Fonzar Hernandes; Terezinha de Jesus Marques-Salles; Hasmik Mkrtchyan; Eliane Maria Soares-Ventura; Edinalva Pereira Leite; Maria Tereza Cartaxo Muniz; Maria Teresa Marquim Nogueira Cornélio; Thomas Liehr; Neide Santos; Maria Luiza Macedo Silva
Journal:  Case Rep Genet       Date:  2012-03-25

10.  Outcome and Prognostic Factors for ETV6/RUNX1 Positive Pediatric Acute Lymphoblastic Leukemia Treated at a Single Institution in Korea.

Authors:  Jae Wook Lee; Seong-Koo Kim; Pil-Sang Jang; Nack-Gyun Chung; Dae-Chul Jeong; Myungshin Kim; Bin Cho; Hack-Ki Kim
Journal:  Cancer Res Treat       Date:  2016-08-10       Impact factor: 4.679

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.